DOAJ Open Access 2023

Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans

A. L. De Sousa-Coelho A. L. De Sousa-Coelho A. L. De Sousa-Coelho R. Rodriguez-Rodriguez R. Rodriguez-Rodriguez +5 lainnya

Lihat Sumber DOI

Topik & Kata Kunci

Diseases of the endocrine glands. Clinical endocrinology

Penulis (10)

A. L. De Sousa-Coelho

R. Rodriguez-Rodriguez

S. Softic

J. W. Jonker

J. Relat

Format Sitasi

APA MLA BibTeX

Sousa-Coelho, A.L.D., Sousa-Coelho, A.L.D., Sousa-Coelho, A.L.D., Rodriguez-Rodriguez, R., Rodriguez-Rodriguez, R., Softic, S. et al. (2023). Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans. https://doi.org/10.3389/fendo.2023.1253675

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →

Lihat di Sumber doi.org/10.3389/fendo.2023.1253675

Informasi Jurnal

Tahun Terbit: 2023
Sumber Database: DOAJ
DOI: 10.3389/fendo.2023.1253675
Akses: Open Access ✓